Medicare Enrolled
Shannon Kimsey, FPA, APRN
Nurse Practitioner - Family · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Kimsey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Kimsey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Kimsey
Shannon Kimsey is a nurse practitioner - family in Chicago, IL, with 12 years of NPI registration. Based on federal Medicare data, Kimsey performed 1,907 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Kimsey received a total of $5,154 from 32 pharmaceutical and/or device companies across 311 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Kimsey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 5% volume in IL
$5,154 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,907
Medicare services
Top 5% in IL for nurse practitioner - family
Not available
Unique patients (not deduplicated)
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
707 | $4 | $10 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
219 | $32 | $99 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
185 | $51 | $131 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
152 | $33 | $84 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
142 | $69 | $165 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
125 | $57 | $149 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
107 | $73 | $188 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
41 | $1 | $57 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
35 | $101 | $246 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
34 | $33 | $74 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
33 | $62 | $162 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
30 | $42 | $107 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
25 | $25 | $82 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $9 | $22 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
17 | $116 | $258 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $107 | $255 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
13 | $4 | $57 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,154
Total received (2021-2024)
Avg $1,288/year across 4 years
Top 4% in IL for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
311
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,280
2023
$1,776
2022
$1,440
2021
$658
Payments by company (2024)
SUN PHARMACEUTICAL INDUSTRIES INC.
$251
Janssen Biotech, Inc.
$238
UCB, Inc.
$216
ABBVIE INC.
$165
PFIZER INC.
$104
Novartis Pharmaceuticals Corporation
$52
Lilly USA, LLC
$44
E.R. Squibb & Sons, L.L.C.
$31
Arcutis Biotherapeutics, Inc.
$30
GENZYME CORPORATION
$27
Amgen Inc.
$23
Regeneron Healthcare Solutions, Inc.
$23
Almirall LLC
$20
Dermavant Sciences, Inc.
$19
Ortho Dermatologics, a division of Bausch Health US, LLC
$18
STRATA Skin Sciences, Inc.
$16
Top 3 companies account for 55.1% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$716
Sun Pharmaceutical Industries Inc.
$569
Lilly USA, LLC
$505
SUN PHARMACEUTICAL INDUSTRIES INC.
$438
PFIZER INC.
$372
Janssen Biotech, Inc.
$329
UCB, Inc.
$299
Novartis Pharmaceuticals Corporation
$298
Amgen Inc.
$245
EPI Health, LLC
$223
Allergan, Inc.
$181
E.R. Squibb & Sons, L.L.C.
$162
GENZYME CORPORATION
$98
Dermavant Sciences, Inc.
$87
Regeneron Healthcare Solutions, Inc.
$81
Almirall LLC
$65
MAYNE PHARMA COMMERCIAL LLC
$63
LEO Pharma Inc.
$59
Incyte Corporation
$53
AbbVie Inc.
$40
MERZ NORTH AMERICA, INC.
$33
STRATA Skin Sciences, Inc.
$32
Arcutis Biotherapeutics, Inc.
$30
Ortho Dermatologics, a division of Bausch Health US, LLC
$30
Galderma Laboratories, L.P.
$26
Verrica Pharmaceuticals Inc.
$26
Fresenius Kabi USA, LLC
$19
Solta Medical, a division of Bausch Health US, LLC
$17
Merz North America, Inc.
$16
MAYNE PHARMA INC.
$16
Helsinn Therapeutics (U.S.), Inc.
$15
Journey Medical Corporation
$13
Top 3 companies account for 34.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · Absorica LD · BOTOX · Bimzelx · CIBINQO · CLODERM · COSENTYX · Cabtreo · Cimzia · DUPIXENT · EUCRISA · Enbrel · HUMIRA · ILUMYA · Ilumya · JUBLIA · Klisyri · OLUMIANT · OPZELURA · ORACEA · Otezla · RINVOQ · SKYRIZI · STELARA · Seysara · Sotyktu · TALTZ · TREMFYA · VALCHLOR · VTAMA · WYNZORA · Winlevi · XTRAC · Xeomin · YCANTH · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family nurse practitioners in nearby ZIP areas
3,148
County median income
$81,797
Nearest hospital to ZIP centroid (approximate)
NORTHWESTERN MEMORIAL HOSPITAL
0.7 mi
0.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Kimsey is a clinical cardiology specialist, with above-average Medicare volume (top 5% in IL).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Kimsey experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Kimsey performed 707 destruction of precancerous skin growths, 2-14 services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Kimsey receive payments from pharmaceutical companies?
Yes. Kimsey received a total of $5,154 from 32 companies across 311 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Kimsey's costs compare to other family nurse practitioners in Chicago?
Kimsey's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Kimsey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Family Nurse Practitioners in Chicago
Browse family nurse practitioners in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in IL
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in IL
Which IL family nurse practitioners receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology